[ad_1]
Corona viral vaccine has proven to be very effective
AFP, quoting the General Manager of “Biontech”, revealed that it is possible to start distributing the Biontech Pfizer vaccine in December.
Drug maker Pfizer and Biontech previously said they can get approval from regulatory agencies in the US and Europe for emergency use of their Covid-19 vaccine next month, after final trial results showed that the vaccine’s success rate was 95 percent, and there were no serious side effects.
The vaccine’s effectiveness was found to be stable across different age groups and ethnicities, which is a promising sign, given that the disease has affected the elderly and certain groups, including black-skinned people, more than others.
The final analysis of the trial comes just one week after initial results showed the vaccine to be more than 90 percent effective. On Monday, Moderna released preliminary data on its vaccine showing it was 94.5 percent effective.
And it turns out that the Pfizer / Biontech vaccine has been 94 percent effective among people 65 and older, which experts described as very important at a time when the virus is spreading around the world with record cases.
